United States Molecular Diagnostics Market Report 2022-2027 featuring prominent players – Roche Diagnostics, Abbott, Myriad Genetics, BioMerieux, Qiagen, Danaher, Bio-rad and GenMark Diagnostics

Global Fluorescent In Situ Hybridization Probe Market Snapshot to 2027 – North America Holds Major Market Share Due to High Incidence Rate of Genetic Disorders

company logo

company logo

Dublin, 05 Dec. 2022 (GLOBE NEWSWIRE) – The “Global Fluorescent In Situ Hybridization Probes Market: Analysis by Product, by Technology, by End User, by Application, by Region Size and Trends with COVID-19 Impact and Forecast Report” until 2027″ has been added to from ResearchAndMarkets.com offer.

The global fluorescent in situ hybridization (FISH) probes market in 2021 was valued at US$1.40 billion. The market value is expected to reach US$2.24 billion by 2027.

A fluorescent in situ hybridization (FISH) probe refers to a subatomic cytogenetic technique that uses fluorescent probes to visualize genetic material. They are used to identify structural and numerical abnormalities of chromosomes, therapeutic drug monitoring and identification of rare genetic diseases.

Compared to the standard cytogenetic (cellular gene) tests traditionally used, FISH tests can identify minute genetic changes that are typically missed under the microscope. These probes are therefore widely used for the diagnosis, outcome prediction and clinical management of cancer and genetic disorders. The market is expected to grow at a CAGR of 8.21% during the forecast period 2022-2027.

Market dynamics:

  • Growth Drivers: One of the most significant factors impacting the global FISH probe market is the increasing prevalence of cancer and genetic disorders. Additionally, growing requirements for in vitro diagnostic (IVD) testing are driving the FISH probe market. The development of automated IVD systems for laboratories and hospitals provides efficient, accurate and error-free diagnoses. Additionally, IVD products with molecular diagnostic capabilities provide efficient and accurate results. Thus, with the growth of IVD testing, the fluorescence in situ hybridization probe market is expected to propel in the forecasted years. Moreover, the market has witnessed growth over the past few years, owing to factors such as rapid urbanization, aging population, advancement in technology, and many other factors.

  • Challenges: However, the market faced some challenges in particular, lack of effective scanning solutions and advanced automation capabilities, etc.

  • Trends: The market is expected to grow at a rapid rate over the forecast period, owing to various recent trends such as growing demand for big data, FISH automation, etc. The market players are looking for the third generation technologies in the field of FISH probes. . This includes adding powerful big data analysis tools, an AI algorithm for greater speed and accuracy in data interpretation, access to cloud computing for data management and technology direct imaging for the analysis of dark fields (FISH and immunofluorescence) and bright fields (H&E microscopy, IHC). The growing demand for big data is therefore expected to positively influence the growth of the FISH In Situ Hybridization Probe market over the anticipated years.

COVID-19 impact analysis and way forward:

In 2020, the global FISH in situ hybridization probe market had witnessed an acceleration in its growth rate owing to the terms left behind by the COVID-19. The in situ hybridization probe concept plays a crucial role in studying the biology of the new virus and identifying its potential threats to the human body. Therefore, the governments of various countries and private institutions have increased their funding on the in situ hybridization probe to conduct extensive R&D to understand the related results. However, the lockdown imposed worldwide has affected research processes by slowing them down due to unavailability of manpower and created a gap between supply and demand. However, the global in situ hybridization probe market is expected to grow at a better growth rate.

Competitive Landscape:

The FISH probe market is a fragmented market. The industry is also filled with a myriad of smaller players who are, for the most part, overshadowed by larger players due to their lack of distinctive product differentiation.

Key Players of Global FISH Probes Market are:

  • Thermo Fisher Scientific Inc.

  • Bio-rad Laboratories, Inc.

  • Roche Holdings SA

  • Bio-Techne Corporation

  • Abbott Laboratories

  • PerkinElmer, Inc.

  • Biocare Medical LLC

  • AgilentTechnologies

  • Sysmex Company

  • Abnova Company

  • LGC Group

  • Genemed Biotechnologies, Inc.

  • Danaher Company

Some of the strategies of the major players in the FISH probes market are mergers, acquisitions, and collaborations. For example, in 2022, Bio-rad Laboratories, Inc. announced that the company had entered into an agreement to acquire all of the outstanding shares of Curiosity Diagnostics, Sp. Z. oo from Scope Fluidics, SA (WSE NewConnect: SCP), a Warsaw, Poland-based developer of innovative technology solutions for the medical diagnostics and healthcare markets. While PerkinElmer launched the Cellaca PLX Image Cytometry System, a first-of-its-kind benchtop platform that allows researchers to assess multiple Critical Quality Attributes (CQAs) of cell samples in a single workflow automated.

Main topics covered:

1. Summary

2. Presentation
2.1 FISH (Fluorescent In Situ Hybridization) probe: overview
2.1.1 Definition of the FISH (Fluorescent In Situ Hybridization) probe
2.2 Segmentation of FISH probes: an overview
2.2.1 FISH probe segmentation

3. Global Market Analysis
3.1 Global FISH Probe Market: An Analysis
3.1.1 Global FISH Probe Market: An Overview
3.1.2 Global FISH Probe Market by Value
3.1.3 Global FISH Probes Market by Product (Instrument/Software and Consumables)
3.1.4 Global FISH Probe Market by Technology (Q FISH, Flow FISH and Others)
3.1.5 Global FISH Probes Market by End User (Clinical Procedures, Research and Companion Diagnostics)
3.1.6 Global FISH Probes Market by Application (Cancer Diagnostics and Others)
3.1.7 Global FISH Probes Market by Region (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa)
3.2 Global FISH Probe Market: Product Analysis
3.2.1 Global FISH Probes Market by Product: An Overview
3.2.2 Global FISH Instrument/Software Probes Market by Value
3.2.3 Global FISH Probe Consumables Market by Value
3.3 Global FISH Probe Market: Technology Analysis
3.3.1 Global FISH Probe Market by Technology: An Overview
3.3.2 Global Q FISH Probe Market by Value
3.3.3 Global FISH Flow Probes Market by Value
3.3.4 Global Other Technologies FISH Probes Market by Value
3.4 Global FISH Probes Market: End User Analysis
3.4.1 Global FISH Probes Market by End User: An Overview
3.4.2 Global Clinical Procedures FISH Probe Market by Value
3.4.3 Global Research FISH Probes Market by Value
3.4.4 Global Companion Diagnostic FISH Probes Market by Value
3.5 Global FISH Probe Market: Application Analysis
3.5.1 Global FISH Probes Market by Application: An Overview
3.5.2 Global Cancer Diagnostics FISH Probes Market by Value
3.5.3 Global Other FISH Probes Market by Value

4. Regional Market Analysis

5. Impact of COVID-19
5.1 Impact of COVID-19
5.1.1 Impact of COVID-19 on the FISH Probe Market
5.1.2 Impact of COVID-19 on research and development
5.1.3 Post-COVID-19 Impact on the FISH Probe Market

6. Market dynamics
6.1 Drivers of growth
6.1.1 Growing aging population
6.1.2 Rapid urbanization
6.1.3 Increase in the prevalence of cancer and genetic diseases
6.1.4 Increasing requirements for in vitro diagnostic (IVD) tests
6.1.5 Technological Advances
6.1.6 Advantages of the FISH probe
6.2 Challenges
6.2.1 Growing Shortages of Pathologists
6.2.2 Lack of effective scanning solutions and advanced automation capabilities
6.3 Market trends
6.3.1 Growing demand for big data
6.3.2 FISH Automation

7. Competitive Landscape
7.1 Global FISH Probe Players by Market Share

8. Company Profiles
8.1 Thermo Fisher Scientific Inc.
8.1.1 Overview of activities
8.1.2 Operating segment
8.1.3 Business Strategy
8.2 Bio-rad Laboratories, Inc.
8.2.1 Overview of activities
8.2.2 Operational Segment
8.2.3 Business Strategy
8.3 Roche Holdings AG
8.3.1 Company Overview
8.3.2 Industry
8.3.3 Business Strategy
8.4 Bio-Techne Corporation
8.4.1 Business overview
8.4.2 Operational Segment
8.4.3 Business Strategy
8.5 Abbott Laboratories
8.5.1 Company Overview
8.5.2 Operational Segment
8.5.3 Business strategy
8.6 PerkinElmer, Inc.
8.6.1 Company Overview
8.6.2 Operating segments
8.6.3 Business strategy
8.7 Biocare Medical, LLC
8.7.1 Company Overview
8.7.2 Business Strategy
8.8 Agilent Technologies
8.8.1 Company Overview
8.8.2 Industry
8.8.3 Business Strategy
8.9 Sysmex Company
8.9.1 Company Overview
8.9.2 Industry
8.9.3 Business strategy
8.10 Abnova Corporation
8.10.1 Company Overview
8.11 LGC Group
8.11.1 Company Overview
8.11.2 Business Strategy
8.12 Genemed Biotechnologies, Inc.
8.12.1 Company Overview
8.13 Danaher Company
8.13.1 Company Overview
8.13.2 Operating segments
8.13.3 Business Strategy

For more information about this report visit https://www.researchandmarkets.com/r/hayte9

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

#Global #Fluorescent #Situ #Hybridization #Probe #Market #Snapshot #North #America #Holds #Major #Market #Share #Due #High #Incidence #Rate #Genetic #Disorders

Leave a Comment

Your email address will not be published. Required fields are marked *